Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by inventorson Nov 24, 2015 2:53pm
198 Views
Post# 24320849

RE:Piper Jaffray

RE:Piper JaffrayBy invitation only...Piper Jaffay just invested $40 M into Veracyte...idiopathic pulmonary fibrosis...diagnostics mainly. They also partnered with GE...whats up...lol.


https://pulmonaryfibrosisnews.com/2015/04/27/veracyte-closes-40-million-private-placement-transaction/

Nasdaq, naturally...

https://ca.finance.yahoo.com/echarts?s=VCYT#symbol=VCYT;range=
Bullboard Posts